EKSO Annual Cash & Cash Equivalents
$8.64 M
-$11.89 M-57.91%
31 December 2023
Summary:
As of January 23, 2025, EKSO annual cash & cash equivalents is $8.64 million, with the most recent change of -$11.89 million (-57.91%) on December 31, 2023. During the last 3 years, it has fallen by -$4.22 million (-32.84%). EKSO annual cash & cash equivalents is now -78.62% below its all-time high of $40.41 million, reached on December 31, 2021.EKSO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EKSO Quarterly Cash And Cash Equivalents
$8.29 M
+$2.41 M+40.90%
30 September 2024
Summary:
As of January 23, 2025, EKSO quarterly cash and cash equivalents is $8.29 million, with the most recent change of +$2.41 million (+40.90%) on September 30, 2024. Over the past year, it has increased by +$2.41 million (+40.90%). EKSO quarterly cash and cash equivalents is now -83.26% below its all-time high of $49.54 million, reached on March 31, 2021.EKSO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EKSO Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -57.9% | +40.9% |
3 y3 years | -32.8% | -80.9% |
5 y5 years | +12.8% | +2.9% |
EKSO Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -78.6% | at low | -79.5% | +40.9% |
5 y | 5-year | -78.6% | at low | -83.3% | +40.9% |
alltime | all time | -78.6% | >+9999.0% | -83.3% | >+9999.0% |
Ekso Bionics Holdings Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $8.29 M(+40.9%) |
June 2024 | - | $5.88 M(-33.1%) |
Mar 2024 | - | $8.80 M(+1.9%) |
Dec 2023 | $8.64 M(-57.9%) | $8.64 M(-13.1%) |
Sept 2023 | - | $9.94 M(-25.3%) |
June 2023 | - | $13.31 M(-18.2%) |
Mar 2023 | - | $16.28 M(-20.7%) |
Dec 2022 | $20.52 M(-49.2%) | $20.52 M(-29.7%) |
Sept 2022 | - | $29.18 M(-8.6%) |
June 2022 | - | $31.91 M(-11.8%) |
Mar 2022 | - | $36.18 M(-10.5%) |
Dec 2021 | $40.41 M(+214.2%) | $40.41 M(-7.0%) |
Sept 2021 | - | $43.44 M(-5.4%) |
June 2021 | - | $45.94 M(-7.3%) |
Mar 2021 | - | $49.54 M(+285.2%) |
Dec 2020 | $12.86 M(+18.3%) | $12.86 M(-11.6%) |
Sept 2020 | - | $14.55 M(+9.7%) |
June 2020 | - | $13.26 M(+55.7%) |
Mar 2020 | - | $8.52 M(-21.7%) |
Dec 2019 | $10.87 M(+42.0%) | $10.87 M(+34.9%) |
Sept 2019 | - | $8.06 M(-39.2%) |
June 2019 | - | $13.26 M(+43.6%) |
Mar 2019 | - | $9.24 M(+20.7%) |
Dec 2018 | $7.66 M | $7.66 M(-41.1%) |
Sept 2018 | - | $12.99 M(-6.4%) |
June 2018 | - | $13.89 M(-32.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $20.57 M(-26.0%) |
Dec 2017 | $27.81 M(+65.1%) | $27.81 M(-16.8%) |
Sept 2017 | - | $33.44 M(+212.5%) |
June 2017 | - | $10.70 M(+13.5%) |
Mar 2017 | - | $9.43 M(-44.0%) |
Dec 2016 | $16.85 M(-13.8%) | $16.85 M(+31.6%) |
Sept 2016 | - | $12.80 M(+174.6%) |
June 2016 | - | $4.66 M(-62.1%) |
Mar 2016 | - | $12.31 M(-37.0%) |
Dec 2015 | $19.55 M(-22.4%) | $19.55 M(+74.0%) |
Sept 2015 | - | $11.24 M(-30.8%) |
June 2015 | - | $16.25 M(-23.1%) |
Mar 2015 | - | $21.13 M(-16.1%) |
Dec 2014 | $25.19 M(>+9900.0%) | $25.19 M(+251.0%) |
Sept 2014 | - | $7.18 M(-34.6%) |
June 2014 | - | $10.97 M(-24.8%) |
Mar 2014 | - | $14.58 M(>+9900.0%) |
Dec 2013 | - | $100.00(-75.0%) |
Sept 2013 | - | $400.00(-78.9%) |
June 2013 | - | $1900.00(-93.5%) |
Mar 2013 | - | $29.20 K(-2.7%) |
Mar 2013 | $29.20 K(+247.6%) | - |
Dec 2012 | - | $30.00 K(+136.2%) |
Sept 2012 | - | $12.70 K(+144.2%) |
June 2012 | - | $5200.00 |
Mar 2012 | $8400.00 | - |
FAQ
- What is Ekso Bionics Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ekso Bionics Holdings?
- What is Ekso Bionics Holdings annual cash & cash equivalents year-on-year change?
- What is Ekso Bionics Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Ekso Bionics Holdings?
- What is Ekso Bionics Holdings quarterly cash and cash equivalents year-on-year change?
What is Ekso Bionics Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of EKSO is $8.64 M
What is the all time high annual cash & cash equivalents for Ekso Bionics Holdings?
Ekso Bionics Holdings all-time high annual cash & cash equivalents is $40.41 M
What is Ekso Bionics Holdings annual cash & cash equivalents year-on-year change?
Over the past year, EKSO annual cash & cash equivalents has changed by -$11.89 M (-57.91%)
What is Ekso Bionics Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EKSO is $8.29 M
What is the all time high quarterly cash and cash equivalents for Ekso Bionics Holdings?
Ekso Bionics Holdings all-time high quarterly cash and cash equivalents is $49.54 M
What is Ekso Bionics Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, EKSO quarterly cash and cash equivalents has changed by +$2.41 M (+40.90%)